Article citationsMore>>

Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M. and Markowitz, M. (1995) Rapid Turnover of Plasma Virions and CD4 Lymphocytes in HIV-1 Infection. Nature, 273, 123-126.
http://dx.doi.org/10.1038/373123a0

has been cited by the following article:

• TITLE: On Analysis of Parameter Estimation Model for the Treatment of Pathogen-Induced HIV Infectivity

  AUTHORS: Bassey E. Bassey, Lebedev K. Andreyevich

  KEYWORDS: Asymptomatic-Stage, De-Replication, Discretization, Infectivity, Mutation-Ability

  JOURNAL NAME: Open Access Library Journal, Vol.3 No.4, April 22, 2016

  ABSTRACT: Multiplicity of new cases of HIV/AIDS and its allied infectious diseases daunted by lack of proper parametric estimation necessitated this present work. Formulated using ordinary differential equation was a five-dimensional (5D) differential mathematical model with which compatibility of optimal control strategy for dual (viral load and parasitoid-pathogen) infectivity in the blood plasma was investigated. Discretization method indicated the incompatibility of the model due to large error derivatives. The study using numerical method established treatment set point with which we explored the variation of predominant model parameters and thereof investigated the maximization of uninfected healthy CD4 T cell count as well as the de-replication of viruses following the consistent administration of reverse transcriptase inhibitor from set point. Presented was a series of numerical calculations obtained using well-known Runge-Kutter of order of precision 4, in Mathcad platform. Analysis of simulated parameters showed that distortion of replication viruses and de-transmutation of susceptible CD4 T cells by viruses via chemotherapy led to restoration and gradual increase of healthy blood plasma, with near zero declination of both viral load and parasitoid-pathogen within chemotherapy validity time frame. The model was worthy in the study of treatment analysis of dual HIV—pathogen infection and thereof recommended for other related dual infectious diseases.